EP Patent

EP2008651A1 — A bioerodible patch

Assigned to MC2 Therapeutics Ltd · Expires 2008-12-31 · 17y expired

What this patent protects

A bioerodible patch comprising at least one bioadhesive layer and at least one non-bioadhesive layer, wherein the bioadhesive layer comprises at least one polyaphron dispersion and at least one bioadhesive polymer, and wherein the polyaphron dispersion comprises at least one phar…

USPTO Abstract

A bioerodible patch comprising at least one bioadhesive layer and at least one non-bioadhesive layer, wherein the bioadhesive layer comprises at least one polyaphron dispersion and at least one bioadhesive polymer, and wherein the polyaphron dispersion comprises at least one pharmaceutically active agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP2008651A1
Jurisdiction
EP
Classification
—
Expires
2008-12-31
Drug substance claim
No
Drug product claim
No
Assignee
MC2 Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.